Enrollment of phase 3 trial of RPC1063 in RRMS begins
Posted: Tue Jan 07, 2014 2:25 am
Receptos, Inc. announced today that the Company has enrolled the first patients in the Phase 3 portion of RADIANCE, its Phase 2/3 study of RPC1063 in relapsing multiple sclerosis (RMS). The announcement follows the review of interim analysis of the Phase 2 portion of the study which was announced in December 2013....... Read More - http://www.ms-uk.org/RPC1063